Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02635204
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 267
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Large-scale testing (Phase 3)Study completedNCT07008547
What this trial is testing

To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
SPH-BIOCAD (HK) Limited 202
Large-scale testing (Phase 3)Study completedNCT07746479
What this trial is testing

Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )

Who this might be right for
Psoriasis
Livzon Pharmaceutical Group Inc. 244
Large-scale testing (Phase 3)Study completedNCT04930042
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Alvotech Swiss AG 581
Large-scale testing (Phase 3)Study completedNCT02982005
What this trial is testing

KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Korea Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT02826603
What this trial is testing

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,114
Early research (Phase 1)Looking for participantsNCT05642182
What this trial is testing

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Who this might be right for
Psoriasis
SFA Therapeutics 90
Post-approval studies (Phase 4)Study completedNCT01745133
What this trial is testing

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Leon Kircik, M.D. 63
Large-scale testing (Phase 3)Study completedNCT01001208
What this trial is testing

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Who this might be right for
Psoriasis
Amgen 478
Testing effectiveness (Phase 2)Looking for participantsNCT07233291
What this trial is testing

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

Who this might be right for
Psoriasis (PsO)
Ahmed Ibrahim 36
Post-approval studies (Phase 4)WithdrawnNCT04488185
What this trial is testing

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05272150
What this trial is testing

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

Who this might be right for
Plaque PsoriasisScalp Psoriasis
Janssen Research & Development, LLC 211
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Large-scale testing (Phase 3)Study completedNCT01726933
What this trial is testing

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 839
Large-scale testing (Phase 3)Study completedNCT02362789
What this trial is testing

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 132
Large-scale testing (Phase 3)UnknownNCT06110676
What this trial is testing

Evaluate the Efficacy and Safety of LZM012

Who this might be right for
Psoriasis
Livzon Pharmaceutical Group Inc. 918
Large-scale testing (Phase 3)Study completedNCT03875482
What this trial is testing

Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 157
Early research (Phase 1)Ended earlyNCT02502188
What this trial is testing

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
ParapsoriasisHealthy Volunteers
Celgene 24
Not applicableStudy completedNCT01077232
What this trial is testing

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 5,442
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation